We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Top Buys

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.7M
2
IMVT icon
Immunovant
IMVT
+$15.7M
3
LL
LL Flooring Holdings, Inc.
LL
+$11.4M
4
ACET icon
Adicet Bio
ACET
+$10.9M
5
INVZ icon
Innoviz Technologies
INVZ
+$9.95M

Top Sells

Rank Stock Value
1
ARKK icon
ARK Innovation ETF
ARKK
+$131M
2
IMCR icon
Immunocore
IMCR
+$34.1M
3
FTAI icon
FTAI Aviation
FTAI
+$28.1M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$20.8M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$14.4M

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSRXW
626
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$766 ﹤0.01%
150,309
+128,660
+594% +$2.82K
EPHYW
627
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$738 ﹤0.01%
321,258
+94,065
+41% +$2.61K
ENTFW
628
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Warrant
ENTFW
$723 ﹤0.01%
+24,100
New +$974
CXAC.WS
629
DELISTED
C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
CXAC.WS
$690 ﹤0.01%
+23,000
New +$1.13K
GVCIW
630
DELISTED
Green Visor Financial Technology Acquisition Corp. I Warrants
GVCIW
$625 ﹤0.01%
62,500
+12,500
+25% +$376
AONCW
631
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$617 ﹤0.01%
10,287
-114,713
-92% -$9.38K
WEJOW
632
DELISTED
Wejo Group Limited Warrant
WEJOW
$610 ﹤0.01%
12,254
-14,006
-53% -$1.17K
DISAW
633
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$594 ﹤0.01%
49,566
+100
+0.2% +$3
NSTD.WS
634
DELISTED
Northern Star Investment Corp. IV Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTD.WS
$582 ﹤0.01%
+24,999
New +$777
ITQRW
635
DELISTED
Itiquira Acquisition Corp. Warrant
ITQRW
$559 ﹤0.01%
74,608
+24,608
+49% +$421
GLLIW
636
DELISTED
Globalink Investment Inc. Warrants
GLLIW
$552 ﹤0.01%
50,200
+100
+0.2% +$2
KRNLW
637
DELISTED
Kernel Group Holdings, Inc. Warrants
KRNLW
$525 ﹤0.01%
92,166
+6,945
+8% +$119
MNTN.WS
638
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
$504 ﹤0.01%
33,400
-600
-2% -$22
GDSTW
639
DELISTED
Goldenstone Acquisition Limited Warrants
GDSTW
$489 ﹤0.01%
444,676
-300
-0.1% -$5
ATIP.WS
640
DELISTED
ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ATIP.WS
$407 ﹤0.01%
75,400
-200
-0.3% -$9
BETRW icon
641
Better Home & Finance Warrant
BETRW
$1.85M
$375 ﹤0.01%
25,000
– –
CPARW
642
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
$360 ﹤0.01%
212,318
-142,404
-40% -$6.86K
LGACW
643
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$351 ﹤0.01%
58,661
+25,321
+76% +$674
C icon
644
CALL
Citigroup
C
$228B
$337 ﹤0.01%
+67,400
New +$3.06M
FOXO.WS
645
DELISTED
FOXO Technologies Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FOXO.WS
$302 ﹤0.01%
+11,250
New +$663
SAMAW
646
DELISTED
Schultze Special Purpose Acquisition Corp. II Warrant
SAMAW
$276 ﹤0.01%
+24,492
New +$899
FRONW
647
DELISTED
Frontier Acquisition Corp. Warrant
FRONW
$256 ﹤0.01%
22,116
+6,166
+39% +$367
AILEW
648
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$253 ﹤0.01%
50,651
-20,249
-29% -$464
SCOBW
649
DELISTED
ScION Tech Growth II Warrants
SCOBW
$225 ﹤0.01%
62,722
-4,778
-7% -$76
VEEAW
650
Veea Inc Warrant
VEEAW
$504K
$223 ﹤0.01%
12,200
+900
+8% +$33
24 25
26
27 28

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.